Data / Form D filings / Solaris Endovascular Inc.
Solaris Endovascular Inc.: Form D filing
Solaris Endovascular Inc., a biotechnology company in Dallas, TX, filed a Form D with the SEC in 2026. The latest, on October 1, 2026, reports $5 million sold of a $10 million offering to 45 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3232 MCKINNEY AVENUE SUITE 500, Dallas, TX, 75204
- Phone
- (215) 688-6196
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2156481
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1 | New notice | $10,000,000 | $4,972,500 | $5,027,500 | 45 | Sep 5 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Randolph W. Hubbell | Executive Officer, Director | |
| Alexander Marra Moreira | Director | |
| Melchiades de Cunha Neto | Director | |
| Marco Costa | Director | |
| David Stack | Director | |
| Matthew Head | Executive Officer |
Other biotechnology companies in Texas that filed recently
- OncoNano Medicine, Inc. $10.1 million · Oct 8
Every Form D from the week of Sep 28 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Solaris Endovascular Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.